206
Participants
Start Date
June 13, 2022
Primary Completion Date
June 30, 2027
Study Completion Date
August 31, 2027
Osilodrostat
oral administration of Osilodrostat tablets at different doses according to patient's need
Radboud University Nijmegen, Nijmegen
NYU Grossman School of Medicine, New York
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
Charité Universitaetsmedizin Berlin, Berlin
Medicover Berlin-Mitte MVZ, Berlin
Hopital de la Conception - APHM, Marseille
University of Pennsylvania Medical Center, Philadelphia
Amedes Experts, Hamburg
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Medicover MVZ Oldenburg, Oldenburg
Emory University School, Atlanta
Hopital Larrey, Toulouse
Hôpital Haut-Lévêque, Bordeaux
CHU de Grenoble site Nord, Grenoble
St Elizabeth Physicians, Covington
Endocrinology Research Associates, Inc., Columbus
CHU de Nantes-Hopital Laennec, Nantes
Indiana University Schl-med, Indianapolis
University of Michigan, Ann Arbor
Medicover Köln, Cologne
Froedtert Hospital, Milwaukee
Hôpital de Brabois, Nancy
Mayo Clinic - Rochester, Rochester
Hopital Claude Huriez - CHRU Lille, Lille
Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona
Universitaetsklinikum Frankfurt Goethe-Universitaet, Frankfurt
Endokrinologikum Frankfurt, Frankfurt
Northwestern University, Chicago
Washington University School of Medicine, St Louis
Hospices Civiles de Lyon, Bron
Hôpital Cochin, Paris
"Azienda Ospedaliera Universitaria Federico II", Napoli
Medicover Neuroendokrinologie, Munich
Barrow Neurological Institute, Phoenix
Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre
Universitaetsklinikum Wuerzburg, Würzburg
Oregon Health And Science University, Portland
Massachusetts General Hospital, Boston
Universitaet Bielefeld - Klinikum Bielefeld - Mitte, Düsseldorf
Ludwig-Maximilians University of Munich, Munich
Policlinico Umberto I, Roma
Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza, Roma
Erasmus MC, Rotterdam
RECORDATI GROUP
INDUSTRY